Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus
The low-density lipoprotein receptor (LDLR) is the first described receptor for apolipoprotein E (apoE). We hypothesize that the absence of the LDLR, similar to the absence of apoE, results in impaired learning and memory processes. Six-month-old homozygous Ldlr−/− and wild-type littermates (Ldlr+/+...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-06-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996104000233 |
id |
doaj-27165d6704a24a998a03fb081c06fdfb |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Monique Mulder Paula J Jansen Ben J.A Janssen Wilma D.J van de Berg Hans van der Boom Louis M Havekes Ron E de Kloet Frans C.S Ramaekers Arjan Blokland |
spellingShingle |
Monique Mulder Paula J Jansen Ben J.A Janssen Wilma D.J van de Berg Hans van der Boom Louis M Havekes Ron E de Kloet Frans C.S Ramaekers Arjan Blokland Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus Neurobiology of Disease Apolipoprotein E Alzheimer's disease Lipid metabolism Low-density lipoprotein receptor family Memory |
author_facet |
Monique Mulder Paula J Jansen Ben J.A Janssen Wilma D.J van de Berg Hans van der Boom Louis M Havekes Ron E de Kloet Frans C.S Ramaekers Arjan Blokland |
author_sort |
Monique Mulder |
title |
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
title_short |
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
title_full |
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
title_fullStr |
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
title_full_unstemmed |
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
title_sort |
low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
2004-06-01 |
description |
The low-density lipoprotein receptor (LDLR) is the first described receptor for apolipoprotein E (apoE). We hypothesize that the absence of the LDLR, similar to the absence of apoE, results in impaired learning and memory processes. Six-month-old homozygous Ldlr−/− and wild-type littermates (Ldlr+/+), maintained on a standard lab chow diet, were used. Unlike humans, Ldlr−/− mice, under these conditions, do not develop atherosclerosis. The results of the Morris water escape task revealed an impaired spatial memory in the Ldlr−/− mice in comparison with Ldlr+/+ mice. Also in a T-maze task, the working memory performance of the Ldlr−/− mice was impaired. Furthermore, Ldlr−/− mice, in comparison with Ldlr+/+ mice, display a decreased number of synaptophysin-immunoreactive presynaptic boutons in the hippocampus CA1. In conclusion, the results show in mice deficiency for the LDLR results in impaired hippocampal-dependent memory functions. A decrease in the number of presynaptic boutons may underlay these behavioral alterations. Therefore, the LDLR may be an important receptor for apoE in the central nervous system. |
topic |
Apolipoprotein E Alzheimer's disease Lipid metabolism Low-density lipoprotein receptor family Memory |
url |
http://www.sciencedirect.com/science/article/pii/S0969996104000233 |
work_keys_str_mv |
AT moniquemulder lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT paulajjansen lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT benjajanssen lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT wilmadjvandeberg lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT hansvanderboom lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT louismhavekes lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT ronedekloet lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT franscsramaekers lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus AT arjanblokland lowdensitylipoproteinreceptorknockoutmicedisplayimpairedspatialmemoryassociatedwithadecreasedsynapticdensityinthehippocampus |
_version_ |
1724211989548367872 |
spelling |
doaj-27165d6704a24a998a03fb081c06fdfb2021-03-20T04:49:28ZengElsevierNeurobiology of Disease1095-953X2004-06-01161212219Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampusMonique Mulder0Paula J Jansen1Ben J.A Janssen2Wilma D.J van de Berg3Hans van der Boom4Louis M Havekes5Ron E de Kloet6Frans C.S Ramaekers7Arjan Blokland8Department of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsDepartment of Molecular Cell Biology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pharmacology and Toxicology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Department of Pediatrics/Cellular Neuroscience, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands; Gaubius Laboratory, TNO-Prevention and Health, Leiden University, Leiden, The Netherlands; Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; Department of Psychology, Maastricht University and University Hospital Maastricht, Maastricht, The NetherlandsThe low-density lipoprotein receptor (LDLR) is the first described receptor for apolipoprotein E (apoE). We hypothesize that the absence of the LDLR, similar to the absence of apoE, results in impaired learning and memory processes. Six-month-old homozygous Ldlr−/− and wild-type littermates (Ldlr+/+), maintained on a standard lab chow diet, were used. Unlike humans, Ldlr−/− mice, under these conditions, do not develop atherosclerosis. The results of the Morris water escape task revealed an impaired spatial memory in the Ldlr−/− mice in comparison with Ldlr+/+ mice. Also in a T-maze task, the working memory performance of the Ldlr−/− mice was impaired. Furthermore, Ldlr−/− mice, in comparison with Ldlr+/+ mice, display a decreased number of synaptophysin-immunoreactive presynaptic boutons in the hippocampus CA1. In conclusion, the results show in mice deficiency for the LDLR results in impaired hippocampal-dependent memory functions. A decrease in the number of presynaptic boutons may underlay these behavioral alterations. Therefore, the LDLR may be an important receptor for apoE in the central nervous system.http://www.sciencedirect.com/science/article/pii/S0969996104000233Apolipoprotein EAlzheimer's diseaseLipid metabolismLow-density lipoprotein receptor familyMemory |